⌘K

Login Start Free

Home/Insiders/McClure Matthew W.

MM

SEC Insider//CIK 0001927121

McClure Matthew W.

CIK 00019271211 companySOUTH SAN FRANCISCO, CA

Transactions

10

Companies

1

Filings

5

CIK

0001927121

Recent Transactions

10 trades

Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2024-03-01+72,000→ 72,000 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2024-02-28+75,183→ 75,183 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2024-02-28+16,428→ 16,428 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2024-02-28+65,713→ 65,713 total
Disposition to Issuer
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2024-02-27−23,000→ 0 total
Disposition to Issuer
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2024-02-27−92,000→ 0 total
Disposition to Issuer
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2024-02-27−255,626→ 0 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2023-09-08+48,000→ 48,000 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2023-03-15+75,000→ 75,000 total
Award
Aligos Therapeutics, Inc.$ALGS
Stock Option (Right to Buy)
2022-07-07+46,000→ 46,000 total

Companies

1

Aligos Therapeutics, Inc.
Chief Medical Officer
$ALGS

Recent Filings

5

Address

C/O ALIGOS THERAPEUTICS, INC. ONE CORPORATE DR., 2ND FLOOR

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov